Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Tipepidine
2. Tipepidine Citrate (1:1)
3. Tipepidine Ibenzato
1. 31139-87-4
2. Asverin H
3. 3-(dithiophen-2-ylmethylidene)-1-methylpiperidine;2-(4-hydroxybenzoyl)benzoic Acid
4. Antupex(tipepidine Hibenzate)
5. Asverin (tn)
6. Antupex
7. Sotal
8. Tipepidine Hibenzate (jp17)
9. Chebi:32231
10. Dtxsid00185068
11. Tipepidine Hibenzate [mi]
12. Bcp10380
13. Tipepidine Hibenzate [mart.]
14. Tipepidine Hibenzate [who-dd]
15. Akos015888134
16. Ft-0638953
17. D01495
18. A820737
19. Q27266638
20. 3-(dithiophen-2-ylmethylene)-1-methylpiperidine 2-(4-hydroxybenzoyl)benzoate
21. 3-(dithiophen-2-ylmethylidene)-1-methylpiperidine,2-(4-hydroxybenzoyl)benzoic Acid
22. 3-[bis(2-thienyl)methylene]-1-methyl-piperidine; 2-(4-hydroxybenzoyl)benzoic Acid
23. Piperidine, 3-(di-2-thienylmethylene)-1-methyl-, 2-(4-hydroxybenzoyl)benzoate
24. 3-(di(thiophen-2-yl)methylidene)-1-methylpiperidin-1-ium 2-(4-hydroxybenzoyl)benzoate (1:1)
| Molecular Weight | 517.7 g/mol |
|---|---|
| Molecular Formula | C29H27NO4S2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 5 |
| Exact Mass | 517.13815069 g/mol |
| Monoisotopic Mass | 517.13815069 g/mol |
| Topological Polar Surface Area | 134 Ų |
| Heavy Atom Count | 36 |
| Formal Charge | 0 |
| Complexity | 626 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A 31139-87-4 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 31139-87-4, including repackagers and relabelers. The FDA regulates 31139-87-4 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 31139-87-4 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 31139-87-4 supplier is an individual or a company that provides 31139-87-4 active pharmaceutical ingredient (API) or 31139-87-4 finished formulations upon request. The 31139-87-4 suppliers may include 31139-87-4 API manufacturers, exporters, distributors and traders.
click here to find a list of 31139-87-4 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 31139-87-4 Drug Master File in Japan (31139-87-4 JDMF) empowers 31139-87-4 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 31139-87-4 JDMF during the approval evaluation for pharmaceutical products. At the time of 31139-87-4 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 31139-87-4 suppliers with JDMF on PharmaCompass.
31139-87-4 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 31139-87-4 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 31139-87-4 GMP manufacturer or 31139-87-4 GMP API supplier for your needs.
A 31139-87-4 CoA (Certificate of Analysis) is a formal document that attests to 31139-87-4's compliance with 31139-87-4 specifications and serves as a tool for batch-level quality control.
31139-87-4 CoA mostly includes findings from lab analyses of a specific batch. For each 31139-87-4 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
31139-87-4 may be tested according to a variety of international standards, such as European Pharmacopoeia (31139-87-4 EP), 31139-87-4 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (31139-87-4 USP).
LOOKING FOR A SUPPLIER?
